Is migraine a risk factor for the occurrence of eating disorders? Prevalence and biochemical evidences.
The eating disorders (ED), anorexia nervosa (AN) and bulimia nervosa (BN), are severe psychiatric and somatic conditions occurring mainly in young woman. Although the aetiology is largely unknown, same evidences suggest that biological and psychological factors play a relevant role in the pathogenesis, along with monoamine, indole and same hypothalamic hormonal dysfunctions. Migraine is characterized by similar metabolic and psychological anomalies suggesting that a possible relationship exists between the two pathological conditions. To understand the possible relationship between migraine and ED, we have investigated the prevalence of migraine and the other primary headaches in a large group of AN and BN patients. In addition, we have studied the role of tyrosine metabolism in the same group of AN and BN young woman sufferers. In particular, we measured plasma levels of elusive amines: tyramine (Tyr) and octopamine (Oct) and catecholamines: noradrenalin (NE), dopamine (DA). The results of this study show that the prevalence of migraine in the woman affected by ED is very high (<75 %). The levels of Tyr and DA were higher and levels of NE were lower in the ED patients in respect to the control subjects. These biochemical findings suggest that abnormalities of limbic and hypothalamic circuitries play a role in the pathogenesis of ED. The very high prevalence of migraine in our group of ED sufferers and the biochemical profile of migraine, similar to that of ED patients shown in this study, suggest that migraine may constitute a risk factor for the occurrence of ED in young females. This hypothesis is supported by the onset of migraine attacks that initiated, in the majority of the patients, before the occurrence of ED symptoms.
Biochemistry Laboratory for the Study of Primary Headaches and Neurological Diseases, Research and Innovation SpA, Padova, Italy. info@researchinnovation.com
Giovanni
G
D'Andrea
Roberto
R
Ostuzzi
Andrea
A
Bolner
Davide
D
Colavito
Alberta
A
Leon
D000293:Adolescent; D000328:Adult; D000856:Anorexia Nervosa / Q000097:blood* / Q000453:epidemiology*; D015415:Biomarkers / Q000097:blood; D001923:Brain Chemistry / Q000502:physiology; D052018:Bulimia Nervosa / Q000097:blood* / Q000453:epidemiology*; D004298:Dopamine / Q000097:blood; D001068:Feeding and Eating Disorders / Q000097:blood / Q000453:epidemiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000097:blood* / Q000453:epidemiology*; D009638:Norepinephrine / Q000097:blood; D009655:Octopamine / Q000097:blood; D015995:Prevalence; D012307:Risk Factors; D014439:Tyramine / Q000097:blood; D055815:Young Adult
D015415:Biomarkers; D009655:Octopamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine